The chain has entered into a 5-year agreement with Anthem’s IngenioRx.
NCPA CEO B. Douglas Hoey, RPh, MBA, discusses the problems and opportunities facing independent pharmacies.
A new NCPA report highlights the role of community pharmacies.
Is Amazon getting in on the PBM game?
The chain’s PBM will limit opioid prescriptions, along with a host of other opioid safety programs.
Check out the latest changes to the Express Scripts formulary
The PBM giant is cutting down on the number of opioids new patients can buy.
Savings from generic and biosimilar drugs are making PBMs and pharmacies, as well as patients, happy.
Biosimilars are now being dispensed from community pharmacies.
NASP takes aim at DIR fees.